Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05375084 |
|---|---|
| Brief Title: | SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation |
| First Submitted : | May 10, 2022 |
| First Submitted that Met QC Criteria : | May 10, 2022 |
| First Posted : | May 16, 2022 |
| Last Update Submitted that Met QC Criteria : | February 14, 2024 |
| Last Update Posted : | February 16, 2024 |